Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Transcenta to Present Clinical Trial Data of TST001 and MSB0254 at 2022 ASCO Annual Meeting 2022-04-29 10:33
Transcenta Announces First Patient Dosed in China Study of Anti-sclerostin Monoclonal Antibody TST002 for the Treatment of Osteoporosis 2022-04-28 17:06
Transcenta Successfully Passed the Audit of EU Qualified Person for the Manufacturing of TST001 2022-04-21 19:20
Transcenta Announces Presentation of Preclinical Data of TST005 at the 2022 American Association for Cancer Research (AACR) Annual Meeting 2022-03-30 19:28
Transcenta Announces Global Clinical Collaboration with Bristol Myers Squibb to Evaluate TST001 in Combination with Opdivo® in Patients with Locally Advanced or Metastatic Gastric / Gastroesophageal Junction Cancer 2022-03-22 08:19
Transcenta Presented Safety / Tolerability and Preliminary Anti-tumor Activity Data in Gastric and Pancreatic Cancers of TST001 Monotherapy from China Phase I Clinical Trial at the 2022 International Gastric Cancer Congress 2022-03-10 08:30
Transcenta Announces First Patient Dosed in Phase IIa Study of Claudin18.2 Monoclonal Antibody TST001 Combined with Cisplatin and Gemcitabine for the First Line Treatment of Biliary Tract Cancer 2022-02-28 10:03
Transcenta to Present Two Phase I Clinical Trials of TST001 at Upcoming ASCO GI and IGCC 2022-01-12 15:15
Transcenta Announces the Appointment of Daniel Weng as CFO 2021-12-17 08:30
1 2 3